Diagnos Laboratorium Utama Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Ikapharmindo Putramas Tbk. are close in size by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 13.7K). Which is the better fit depends on your goals.
| DGNS | IKPM | |
|---|---|---|
Market Cap | 310.75B | 304.92B |
Volume | 963.6K | 13.7K |
Lot | 9.64K | 137 |
Turnover | 217.67M | 2.49M |
Average Price | 225.89 | 181.39 |
Value | 217.67M | 2.49M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →